Dublin, Ireland, 13 November, 2013 – ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results